Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.

NCT01536535 is registered in ClinicalTrials.gov with Connecticut Children's Medical Center as lead sponsor.

NCT NCT01536535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01536535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Lead sponsor
Connecticut Children's Medical Center
Phase
Phase 4
Overall status
Completed
Start date
July 10, 2012
Completion date
April 30, 2018
Enrollment
431 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis